AADPA's ADHDtracker is an innovative, secure web-based app that allows you to track your patients’ ADHD treatment response on any device or platform as long…
Professor Steven Faraone, President of The World Federation of ADHD has lead the development of an International Consensus Statement on ADHD. Professors Mark Bellgrove and…
Watch this special webinar presentation hosted by the ADHD World Federation for optimising outcomes for ADHD and telepsychiatry in addition to strategies for helping children…
While we are all having to make very significant adjustments to follow the everchanging rules and restrictions necessary to reduce the spread of the COVID-19…
Mark Bellgrove and Dave Coghill recently attended the 2019 Eunethydis Conference and the symposium in Nijmegen, Netherlands. Celebrating the work of Prof. Jan Buitelaar, from…
All states and territories within Australia and New Zealand have their own laws about schedule 8 (ie dangerous drugs/poisons) which includes stimulants. Currently, all states…
Attention deficit hyperactivity disorder (ADHD) affects more than 800,000 Australians. A new Deloitte Access Economics report - The Social and Economic Costs of ADHD in Australia…
ADHD research, policy development and professional training in Australia is set to receive funding to the tune of $1.5 million from the Federal Government. The…
Our mission at AADPA is to promote evidence-based research, diagnosis, treatment & management of ADHD for the benefit of Australians with ADHD & their families.
About AADPA
We are committed to working towards enhanced lifetime outcomes for individuals with ADHD and their families.
Learn More
Member Benefits
Gain resources, support and guidance from Australia’s leading professional ADHD community.
Learn More
Membership Types
Our members come from a range of fields including academia, clinical practice, coaching, education and allied healthcare.